The core principle of BETMAT’s Kinetic Chromogenic LAL Assay is based on the specific enzymatic cascade triggered by the interaction between Limulus Amebocyte Lysate (LAL) and bacterial ...

Hit identification and hit validation represent distinct but connected stages of early drug discovery. This article examines ...

Assay miniaturization has become a central strategy in modern high-throughput screening (HTS), enabling laboratories to increase throughput while managing reagent consumption and operational costs. As ...

Cloud-Clone has built an integrated antibody R&D and manufacturing platform, focusing on enhancing product consistency and MP for research and diagnostics. HUSTON, TX, UNITED STAT ...

NEW YORK, NY, UNITED STATES, April 27, 2026 /EINPresswire.com/ -- With years of experience in the pharmaceutical and ...

CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), announced today a new payer coverage agreement with Blue Shield of California, ...

Q2 2026 guidance assumes modest sequential improvement, though management notes that the pace of recovery in the Middle East ...

May 5, 2026, 5 p.m. ET President and Chief Executive Officer — Brian J. Blaser Chief Financial Officer — Joseph M. Busky Vice ...

Navinci today announces the launch of Omni, breakthrough fully customized kits designed to transform how scientists study protein function directly in tissue. Omni provides cutting-edge spatial ...

High-throughput virology, design of experiments, and small-molecule production enhancers optimize yield and increase ...

Viralgen continues its pioneering work in manufacturing science with advancements in key process understanding with analytical tools ...

Autonomous and automated laboratory systems are rapidly transforming the landscape of drug discovery by combining robotics, advanced sensing, and ...